Biotech Values

[DewDiligence]

Re: Repros Therapeutics Inc. Announces Information In Compliance With NASDAQ Marketplace Rule 4350

I haven’t checked the fine print of Rule 4350, but I presume that it specifies a time limit for making the going concern disclosure and I presume that the time limit is less than 316 days (the elapsed time since RPRX filed its 2007 10K). In other words, I suspect that the header of today’s PR is false insofar as the company never actually complied with Rule 4350.